ACTRN12613000201774
Not Yet Recruiting
N/A
For patients with movement disorders undergoing deep brain stimulation of the subthalamic nucleus, can evoked compound action potentials be measured to aid the implant procedure, programming and understanding of mechanisms of the therapy?
ational ICT Australia Ltd0 sites5 target enrollmentFebruary 19, 2013
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Movement Disorder
- Sponsor
- ational ICT Australia Ltd
- Enrollment
- 5
- Status
- Not Yet Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients medically assessed as suitable candidates for Deep Brain Stimulation (DBS) for movement disorders.
- •Patients implanted with a commercially available electrode lead into the STN who are part of a routine DBS implant procedure.
Exclusion Criteria
- •Patients who have had complications during implantation such that the implanted electrodes are not able to stimulate and record in the ST
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
ext Move in Movement DisordersHyperkinetic movement disordersinvoluntary movements1002929910028037NL-OMON52964niversitair Medisch Centrum Groningen534
Completed
N/A
Instrumental assessment of movement disorders in antipsychotic naive patients with autism and healthy controlsAutism10012562NL-OMON35557niversitair Medisch Centrum Utrecht100
Completed
N/A
Adaptive neuromodulation for movement disorders.dystoniaParkinson's disease10028037NL-OMON42422niversitair Medisch Centrum Groningen24
Not Yet Recruiting
Phase 1
Clinical observation on the treatment of non-motor symptoms of Parkinson's disease with Shudi Pingchan prescription combined with repetitive transcranial magnetic stimulatioITMCTR2000003724onghua Hospital Shanghai University of Traditional Chinese Medicine
Completed
N/A
Non Invasive Neuromodulation for Patients With Motor Control DisordersParkinson DiseaseNCT04017481Universidad Francisco de Vitoria50